5,332 Shares in Masimo Co. (NASDAQ:MASI) Purchased by B.O.S.S. Retirement Advisors LLC

B.O.S.S. Retirement Advisors LLC acquired a new stake in Masimo Co. (NASDAQ:MASI) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 5,332 shares of the medical equipment provider’s stock, valued at approximately $881,000.

Other large investors also recently bought and sold shares of the company. UMB Bank n.a. raised its stake in shares of Masimo by 180.9% in the 4th quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider’s stock valued at $32,000 after acquiring an additional 123 shares during the period. Trust Co. of Vermont purchased a new stake in Masimo in the fourth quarter valued at approximately $33,000. NBC Securities Inc. raised its position in Masimo by 47.1% in the third quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 73 shares during the period. Northwestern Mutual Wealth Management Co. raised its position in Masimo by 133.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 200 shares during the period. Finally, GAMMA Investing LLC raised its position in Masimo by 136.5% in the fourth quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider’s stock valued at $77,000 after purchasing an additional 269 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Trading Up 1.3 %

MASI opened at $170.24 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. The company has a market cap of $9.11 billion, a P/E ratio of 117.41 and a beta of 1.01. The business’s 50-day simple moving average is $170.32 and its 200-day simple moving average is $142.15. Masimo Co. has a one year low of $101.61 and a one year high of $180.97.

Masimo (NASDAQ:MASI) last released its earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.14. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The firm had revenue of $504.60 million for the quarter, compared to the consensus estimate of $502.87 million. During the same period in the prior year, the business posted $0.63 earnings per share. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year. As a group, equities research analysts expect that Masimo Co. will post 4.1 EPS for the current fiscal year.

Analyst Ratings Changes

MASI has been the topic of several research analyst reports. Piper Sandler boosted their price objective on Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, December 18th. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a research note on Wednesday. Wells Fargo & Company upped their price objective on Masimo from $171.00 to $193.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 11th. BTIG Research upped their price objective on Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Finally, Raymond James upped their price target on Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a report on Friday, December 27th. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Masimo currently has an average rating of “Moderate Buy” and a consensus price target of $179.67.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.